Vertex Pharmaceuticals Incorporated VRTX Price Target Raised by RBC Amid Positive Regulatory Milestones and Biotech Sector Tailwinds Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline YALA Yalla reports Q4 2025 EPS of 02 slips 015 as investors seek full revenue breakdowns